Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
AstraZeneca
Harvard Business School
Merck
Colorcon

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: nilotinib hydrochloride

See Plans and Pricing

« Back to Dashboard

nilotinib hydrochloride

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Novartis TASIGNA nilotinib hydrochloride CAPSULE;ORAL 022068 NDA Novartis Pharmaceuticals Corporation 0078-0526-51 28 CAPSULE in 1 BLISTER PACK (0078-0526-51)
Novartis TASIGNA nilotinib hydrochloride CAPSULE;ORAL 022068 NDA Novartis Pharmaceuticals Corporation 0078-0526-87 4 BLISTER PACK in 1 CARTON (0078-0526-87) > 28 CAPSULE in 1 BLISTER PACK
Novartis TASIGNA nilotinib hydrochloride CAPSULE;ORAL 022068 NDA Novartis Pharmaceuticals Corporation 0078-0592-51 28 CAPSULE in 1 BLISTER PACK (0078-0592-51)
Novartis TASIGNA nilotinib hydrochloride CAPSULE;ORAL 022068 NDA Novartis Pharmaceuticals Corporation 0078-0592-87 4 BLISTER PACK in 1 CARTON (0078-0592-87) > 28 CAPSULE in 1 BLISTER PACK
Novartis TASIGNA nilotinib hydrochloride CAPSULE;ORAL 022068 NDA Novartis Pharmaceuticals Corporation 0078-0951-66 120 CAPSULE in 1 BOTTLE, PLASTIC (0078-0951-66)
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
Express Scripts
Dow
Merck
Mallinckrodt